Larobina, D.; Franzino, G.; Tescione, F.; Abrami, M.; Tierno, D.; Biasin, A.; Tonon, F.; De Nes, A.; Maggisano, M.; Confalonieri, P.;
et al. Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes. Pharmaceuticals 2026, 19, 681.
https://doi.org/10.3390/ph19050681
AMA Style
Larobina D, Franzino G, Tescione F, Abrami M, Tierno D, Biasin A, Tonon F, De Nes A, Maggisano M, Confalonieri P,
et al. Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes. Pharmaceuticals. 2026; 19(5):681.
https://doi.org/10.3390/ph19050681
Chicago/Turabian Style
Larobina, Domenico, Giorgia Franzino, Fabiana Tescione, Michela Abrami, Domenico Tierno, Alice Biasin, Federica Tonon, Anna De Nes, Marta Maggisano, Paola Confalonieri,
and et al. 2026. "Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes" Pharmaceuticals 19, no. 5: 681.
https://doi.org/10.3390/ph19050681
APA Style
Larobina, D., Franzino, G., Tescione, F., Abrami, M., Tierno, D., Biasin, A., Tonon, F., De Nes, A., Maggisano, M., Confalonieri, P., Carbone, A., Confalonieri, M., Grassi, G., Di Gioia, S., Grassi, M., & Conese, M.
(2026). Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes. Pharmaceuticals, 19(5), 681.
https://doi.org/10.3390/ph19050681